A report from BIVDA and Innovate UK has identified that wider use of some IVD tests could save money and improve patient care.
As we celebrate the 70th anniversary of the NHS is this one way to strengthen its future?
Calprotectin is one of the tests identified in the report. It is already utilised in the NHS, but adopting wider usage by all GP surgeries, to identify IBS patients quicker, is estimated to save £65 million in unnecessary hospital referrals and colonoscopies.
Click here to read the report
